Medindia

X

Celladon Corporation Receives Notice of Allowance by U.S. Patent and Trademark Office for Broad Patent Covering Lead Drug Candidate MYDICAR(R)

Tuesday, March 23, 2010 General News J E 4
Advertisement
Patent to Cover Use of All Adeno-Associated Viral Vectors and Routes of Administration for Delivery of SERCA2a Gene for Treatment of Heart Failure

Contacts:

David Schull or Martina Schwarzkopf, Ph.D.

Russo Partners

212-845-4271

212-845-4292

david.schull@russopartnersllc.com

martina.schwarzkopf@russopartnersllc.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Portola Pharmaceuticals Announces Initiation of Ph...
S
AssureRx Health Promotes Wright to Lead Operations